Zodiac JRD-MKJ Limited has announced the approval of its un-audited financial results for the second quarter and half year ended September 30, 2026. Concurrently, the company’s Board of Directors has also approved the grant of 1,42,066 employee stock options under the Zodiac JRD MKJ Employee Stock Option Plan 2026. These options are exercisable over a period of three years, vesting over a period of three years, and any time after vesting but before completion of 5 years from the date of grant.
Financial Results and Board Approval
In a regulatory filing dated November 3, 2026, Zodiac JRD-MKJ Limited disclosed that its Board of Directors convened a meeting to consider and approve the company’s un-audited financial results for the second quarter and half year ended September 30, 2026. The board also reviewed and approved the Limited Review Report submitted by the statutory auditor.
Employee Stock Option Grant
Furthermore, pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Nomination and Remuneration Committee and the Board of Directors have approved the grant of employee stock options. A total of 1,42,066 stock options were granted under the Zodiac JRD MKJ Employee Stock Option Plan 2026. These options represent 1,42,066 equity shares and are subject to specific vesting and exercise schedules as outlined by the company.
Option Details
The pricing formula/exercise price for these options is ₹10 (Face Value). The options will vest in a graded manner over a period of 3 years. Employees will be able to exercise their vested options anytime after vesting but before the completion of 5 years from the date of grant of options.
Meeting Details
The Board meeting commenced at 03:00 P.M. and concluded at 05:50 P.M. on November 3, 2026.
Source: BSE
